938064-64-3

Basic information

• Product Name: 3-(4-methoxy-benzyloxy)-cyclobutanecarbonitrile
• Synonyms: 3-(4-methoxy-benzyloxy)-cyclobutanecarbonitrile
• CAS NO: 938064-64-3
• Molecular Weight: 217.268
• Mol File: 938064-64-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(4-methoxy-benzyloxy)-cyclobutanecarbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-methoxy-benzyloxy)-cyclobutanecarbonitrile(938064-64-3)
• EPA Substance Registry System: 3-(4-methoxy-benzyloxy)-cyclobutanecarbonitrile(938064-64-3)

Safety Data

• Hazardous Substances Data: 938064-64-3(Hazardous Substances Data)

Upstream product

• 15760-35-7 3-methylenecyclobutanecarbonitrile 
• 20249-16-5 3-oxo-cyclobutanecarbonitrile 
• 20249-17-6 3-hydroxycyclobutane-1-carbonitrile 
• 824-94-2 p-methoxybenzyl chloride 

Relevant articles and documents

2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use

In its many embodiments, the present invention provides certain iminothiazine dioxide compounds, including compounds Formula (I): and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein each of the variables shown in the formula are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including Alzheimer's disease, are also disclosed.

AZETIDINE DERIVATIVES AS GLYT1 INHIBITORS

The present invention relates to compounds of formula (I); and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof, as GIyTl inhibitors for treating neurological and psychiatric disorders.